Lodestar Private Asset Management LLC Gilead Sciences, Inc. Transaction History

Lodestar Private Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	SELL	$71.58 - $87.29 $22,332 - $27,234	-312 Reduced 10.01%	2,804 $205 Million
Q4 2023 Jan 29, 2024	BUY	$73.27 - $83.09 $5,788 - $6,564	79 Added 2.6%	3,116 $252 Million
Q3 2023 Oct 31, 2023	BUY	$73.94 - $80.67 $813 - $887	11 Added 0.36%	3,037 $228 Million
Q2 2023 Jul 27, 2023	BUY	$76.01 - $86.7 $5,624 - $6,415	74 Added 2.51%	3,026 $233 Million
Q1 2023 Apr 25, 2023	BUY	$77.31 - $88.08 $773 - $880	10 Added 0.34%	2,952 $245 Million

Q4 2022 Feb 02, 2023	BUY	$62.32 - $89.47 $183,345 - $263,220	2,942 New	2,942 $253 Million

1,884

8.71M

8.03M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $97.8B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Lodestar Private Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Lodestar Private Asset Management LLC with notifications on news.